Rheumatoid arthritis is a long-term autoimmune disorder that primarily affects joints.
Market Analysis and Insights: Global and United States Rheumatoid Arthritis Treatment Market
This report focuses on global and United States Rheumatoid Arthritis Treatment market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Rheumatoid Arthritis Treatment market size is estimated to be worth US$ 7504.7 million in 2022 and is forecast to a readjusted size of US$ 9023 million by 2028 with a CAGR of 3.1% during the review period. Fully considering the economic change by this health crisis, by Type, Symptomatic Treatment accounting for % of the Rheumatoid Arthritis Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Hospital Pharmacy was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
The rheumatoid arthritis treatment market is expected to grow over the forecast period owing to the high incidence rate of rheumatoid arthritis among people.
Global Rheumatoid Arthritis Treatment Scope and Market Size
Rheumatoid Arthritis Treatment market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Rheumatoid Arthritis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Rheumatoid Arthritis Treatment market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Symptomatic Treatment
Intermediate Corticosteroid Therapies
Disease Modifying Antirheumatic Drug Therapies
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Drug Stores
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Sanofi
Pfizer
Roche
Johnson & Johnson
AbbVie
Eli Lilly
Amgen
Sobi
Bristol-Myers Squibb